Roswell Park Cancer Institute
Buffalo, New York, 14263, United States
NCT Number: NCT03011736
This clinical trial studies the omission of intact parathyroid hormone testing during surgery in treating patients with primary hyperparathyroidism. Omission of intact parathyroid hormone testing during parathyroid gland removal may help patients with primary hyperparathyroidism to decrease their time under anesthesia, and decrease the overall time and cost of surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Buffalo, New York, 14263, United States
PRIMARY OBJECTIVES:
I. Determine the non-inferiority of omission of parathyroid hormone (PTH) in patients who meet the biochemical and radiological criteria compared to current standard of care (i.e. use of intraoperative parathyroid hormone testing).
SECONDARY OBJECTIVES:
I. Cost-analysis to determine savings of omission of intraoperative PTH testing.
OUTLINE:
Patients undergo standard minimally invasive parathyroidectomy without PTH testing during surgery.
After completion of study, patients are followed up at 2 weeks.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Correlative studies
Undergo parathyroidectomy
Time frame: At 2 weeks
Will be evaluated using a binomial exact test. If all N=60 patients achieve cure then the proposed surgery with intraoperative PTH testing committed will be considered non inferior. A 95% confidence interval about pi will be obtained.
Time frame: At 2 weeks
cost analysis will be based on operative time and omission of intraoperative PTH levels.
Roswell Park Cancer Institute
Other
Single-Arm, Non-inferiority Study of Omission of Intraoperative Intact Parathyroid Hormone (PTH) During Minimally Invasive Parathyroidectomy for Primary Hyperparathyroidism
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03039439
Endocrine Gland Neoplasms, Endocrine System Diseases
Houston, Texas, United States
View Trial DetailsNCT06499142
Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Ventura, California, United States
View Trial DetailsNCT05022641
Calcium Metabolism Disorders, Endocrine Gland Neoplasms
Ann Arbor, Michigan, United States
View Trial DetailsNCT04299425
Calcium Metabolism Disorders, Endocrine Gland Neoplasms
Nashville, Tennessee, United States
View Trial Details